Search

everythinglearnresearchcommunity

for

Search:↓

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Minoxidil and finasteride effectively treat hair loss.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.